Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali

about

The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Co-Administered with Measles, Yellow Fever and Meningitis A Vaccines in 9-month-old Malian Infants.

P2860

Q46239950-9D265D7E-FB2E-451B-BDE7-BE886AF2EE30 Q53829816-77242ADA-8010-457A-AAE7-9E072F779E64

P2860

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali

Item

http://www.wikidata.org/entity/Q36265085

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Immunogenicity of Yellow Fever ...... lthy Infants in Ghana and Mali

@ast

Immunogenicity of Yellow Fever ...... lthy Infants in Ghana and Mali

@en

type

Item

label

Immunogenicity of Yellow Fever ...... lthy Infants in Ghana and Mali

@ast

Immunogenicity of Yellow Fever ...... lthy Infants in Ghana and Mali

@en

prefLabel

Immunogenicity of Yellow Fever ...... lthy Infants in Ghana and Mali

@ast

Immunogenicity of Yellow Fever ...... lthy Infants in Ghana and Mali

@en

P1476

Immunogenicity of Yellow Fever ...... lthy Infants in Ghana and Mali

@en

P2093

Brian D Plikaytis

http://www.w3.org/2001/XMLSchema#string

Christian Meier

http://www.w3.org/2001/XMLSchema#string

Godwin C Enwere

http://www.w3.org/2001/XMLSchema#string

Hewad Laraway

http://www.w3.org/2001/XMLSchema#string

Marie-Pierre Preziosi

http://www.w3.org/2001/XMLSchema#string

Panchali Roy Chowdhury

http://www.w3.org/2001/XMLSchema#string

Prasad S Kulkarni

http://www.w3.org/2001/XMLSchema#string

Yuxiao Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Yellow Fever: 100 Years of Discovery

Yellow fever: the recurring plague.

Yellow fever: an update.

Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.

Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies.

Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.

Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?

The phylogeny of yellow fever virus 17D vaccines.

P304

S586-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIV603

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

61 Suppl 5

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Niedrig

Abraham Hodgson

Samba Sow

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283840061

http://www.w3.org/2001/XMLSchema#string

P698

26553692

http://www.w3.org/2001/XMLSchema#string

P921

Gaana

yellow fever virus

Mali

P932

4639505

http://www.w3.org/2001/XMLSchema#string

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali

about

P2860

P2860

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932